HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 20, No 12, December 2016 – Medical Imaging Technology       » Climate Change Could Hurt Coffee, Help Banana Production       » Partnerships and Innovation: Shaping the Future of Healthcare in Asia Pacific       » Chugai's Novel Antibody Technologies Put Singapore at the Centre of Fight Against Disease       » NUS Scientists Discover the "Switch" that Makes Breast Cancer Cells Aggressive      
BIOBOARD - INDONESIA
A blueprint for changing diabetes in Indonesia
Among the 242 million people living in Indonesia, 7.6 million have diabetes but less than 1% is achieving recommended treatment targets. In its fifth Blueprint for Change business case published, Novo Nordisk examines four barriers that prevent quality and accessibility of diabetes care and identifies the opportunities to address them.

“If action is not taken, demand for healthcare will outstrip Indonesia's ability to provide it,” says Charlotte Ersbøll, corporate vice president, Global Stakeholder Engagement, Novo Nordisk. “In the end, it will be people with diabetes and their families that will carry the highest cost.”

The Indonesia Blueprint for Change recommends investments in diabetes awareness, increasing the supply of healthcare professionals specializing in diabetes care and improving diabetes education among internists and general practitioners. Concrete action suggested is the need to involve more levels of healthcare professionals, including nurses and diabetes educators. A final conclusion from the case is the need to make these investments in partnerships.

“Novo Nordisk is committed to working together with local authorities, investors and NGOs to build trust and confidence among patients, healthcare practitioners and policy makers,” says Sandeep Sur, general manager, Novo Nordisk Indonesia. “We must leverage all our joint capabilities and competences if we want to improve knowledge, treatment and better care.”

According to the analysis, improved awareness, accessibility, affordability and quality of care could reduce both diabetes-related complications and costs. Over the remaining lifetime of people with diabetes in Indonesia, more than 37,000 diabetes-related heart attacks and more than 400,000 diabetes-related kidney failures could be prevented, nearly 6 billion USD could be saved in diabetes treatment costs and more than 4.6 million life-years could be gained.

Click here for the complete issue.

NEWS CRUNCH  
news Accuron Technologies' MedTech Division Invests into AWAK Technologies
news Philips introduces PerformanceBridge suite of operational performance improvement software and services for radiology departments
news Give a Gift that Will Last a Lifetime this Holiday Season with Smile Train
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Lungs & Respiratory System
February:
Cancer Research, Treatment/Technology
March:
Traditional Chinese Medicines
April:
Eye Care/ Eye Health
May:
The Piece of Your Mind - Brain Health/Science
June:
Featuring Biotech Start-Ups/Companies
July:
Food Science & Technology
August:
Diabetics Technology
September:
No. 1 Killer - Heart Diseases, Diagnosis and Treatment
October:
Skin Diseases/Allergic Reactions
November:
Diseases threatening our Children
December:
Liver Health & Treatment/Technology
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2016 World Scientific Publishing Co Pte Ltd  •  Privacy Policy